70 /100
HIGH RISK
Score updated Apr 13, 2026

PTHS

Pelthos Therapeutics Inc. — Stock Dilution Tracker

Track PTHS dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

🔔 Track PTHS — Get alerts when the score changes →
📊 Score Breakdown
📋 Offering Ability
60
💰 Cash Runway
65
📊 Float Risk
60
⚠️ Warrant Exposure
15
🔄Convertible Debt
🌦️ Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
26%
🔁 Convertible Conversion 40%
• Significant convertible debt: 24% potential dilution
• Elevated convertible risk (60/100)
💰 Capital Raise 15%
• Under 12 months cash (9mo)
📉 Score Deterioration 10%
• Score in HIGH risk zone (70/100)
🔔 Track PTHS — Get forecast alerts →
💹 Market Data
Market Cap$75.77M
Shares Outstanding3.36M
Float1.35M
Cash$17.97M
Debt$34.83M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↑ 94.9% shares (2025Q4 vs prior)
15 institutional holders · 901.8K shares
#1 Murchinson Ltd. 289.5K shares
#2 Ikarian Capital, LLC 255.8K shares
#3 BOOTHBAY FUND MANAGEMENT, LLC 80.7K shares
+ 12 more holders Sign up free to view →
📉 Short Interest
Short Interest73.0K
Days to Cover17.3
% of Float5.4%
FINRA data as of Mar 31, 2026
📁 Recent SEC Activity
xbrl XBRL CONVERTIBLE Dec 31, 2025
Full SEC filing analysis available with free account
📰 Recent News
No recent news
Track PTHS Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking PTHS — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required